Entering text into the input field will update the search result below

Abiomed +2% after Q3 beat

  • Abiomed (NASDAQ:ABMD) Q3 results: Revenues: $200.6M (+30.3%).
  • Impella pump sales: $193.3M (+31%).
  • Net Income: $44.9M (+235.1%); EPS: $0.97 (+234.5%).
  • FY 2019 Guidance: Revenue: ~$780M from a range of $765M to $770M.
  • The consensus EPS and Revenue estimate were $0.94 and $196.47M, respectively.
  • Shares are up 2% premarket.
  • Previously: Abiomed beats by $0.03, beats on revenue (Jan. 31)

Recommended For You

Related Stocks

SymbolLast Price% Chg
ABMD--
Abiomed, Inc.